G569-0350 Screening compound: N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethanediamide

G569-0350 Screening compound: N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethanediamide
G569-0350 Screening compound: N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G569-0350
N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G569-0350

Molecular Formula

C22H20FN3O4S (C22 H20 FN3 O4 S)

Compound Name

N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethanediamide

IUPAC name

N'-(23-dihydro-14-benzodioxin-6-yl)-N-{2-[2-(3-fluorophenyl)-4-methyl-13-thiazol-5-yl]ethyl}ethanediamide

SMILES

Cc1c(CCNC(C(Nc(cc2)cc3c2OCCO3)=O)=O)sc(-c2cc(F)ccc2)n1

InChI

InChI=1S/C22H20FN3O4S/c1-13-19(31-22(25-13)14-3-2-4-15(23)11-14)7-8-24-20(27)21(28)26-16-5-6-17-18(12-16)30-10-9-29-17/h2-6,11-12H,7-10H2,1H3,(H,24,27)(H,26,28)

InChI Key

RSCISTYLKUGTPE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08009275

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.776

Distribution Coefficient, logD

2.028

Water Solubility, LogSw

-3.46

Polar Surface Area

73.990

Acid Dissociation Constant (pKa)

6.74

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

G569-0350 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G569-0350 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G569-0350?
Check Price and Availability of G569-0350, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G569-0350 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G569-0350
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G569-0350
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G569-0350 available by request